Expert Radar
Dr. Howard Schenker, MD
Ophthalmologist, Rochester Ophthalmological Group
Doctor of Medicine, Weill Cornell Medicine
Dr. Howard I. Schenker has specialized experience in the field of Ophthalmology. They earned their MD from Weill Cornell Medicine. They went on to complete a residency in Ophthalmology at the Icahn School of Medicine at Mount Sinai. Today, the expert holds a certification in Ophthalmology. Currently, they work as an Ophthalmologist at Rochester Ophthalmological Group.
(585) ***-****
Rochester, New York
Get a FREE Demo of Dr. Howard Schenker, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
DISCLAIMER: Expert Institute operates independently and objectively as an expert witness data provider. This listing does not reflect or imply any existing relationship between the expert and Expert Institute. We do not employ, endorse, or maintain any affiliation with the experts listed. Information shown is automatically generated from public sources and may not be current or complete. For verified, in-depth expert data, please contact us to initiate a formal request.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
Media & News
Social Media Mentions
Case Name | Role | Filed Date |
|---|
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0

0
25
50
75
100
Institution | Degree Type |
|---|---|
Weill Cornell Medicine | Doctor of Medicine |
Title | Employer |
|---|---|
Ophthalmologist | Rochester Ophthalmological Group |
— | Medstar Health (Washington, DC) |
— | Icahn School of Medicine at Mount Sinai (New York, NY) |
Title | Type |
|---|---|
Clinical success and quality of life with brimonidine 0.2% or Timolol 0.5% used twice daily in glaucoma or ocular hypertension: A randomized clinical trial | Journal Article |
Long-term intraocular pressure-lowering efficacy and safety of Timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12- month study | Journal Article |
Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.

Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.

